newsfilter
← Latest News
ACCESS Newswire·

Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in the